{"id":12218,"date":"2025-12-16T16:05:49","date_gmt":"2025-12-16T16:05:49","guid":{"rendered":"https:\/\/sescs.es\/?p=12218"},"modified":"2025-12-16T16:05:49","modified_gmt":"2025-12-16T16:05:49","slug":"prognostic-factors-survival-adult-burkitt-lymphoma","status":"publish","type":"post","link":"https:\/\/sescs.es\/en\/prognostic-factors-survival-adult-burkitt-lymphoma\/","title":{"rendered":"SESCS PUBLICATION: Prognostic Factors for Survival in Adults With Burkitt Lymphoma: A Systematic Review"},"content":{"rendered":"<p>Aythami de Armas-Castellano, Diego Infante Ventura, Tasmania del Pino-Sede\u00f1o, Yadira Gonz\u00e1lez Hern\u00e1ndez, Ra\u00fal Quir\u00f3s, Beatriz Le\u00f3n-Salas, Vicente Ribrag, Mar\u00eda M. Trujillo Mart\u00edn, Grupo de trabajo de EuroBlood de la ERN<\/p>\n<p><strong>ABSTRACT<\/strong><\/p>\n<p><strong>Introduction<\/strong><\/p>\n<p>Burkitt lymphoma (BL) is a rare and aggressive subtype of non-Hodgkin&#8217;s lymphoma. Several studies have identified prognostic factors (PFs) for disease progression and mortality among adults with BL. However, there is no consensus on risk stratification based on PFs. This study aims to identify, critically assess, and synthesize the available evidence on PFs for survival in adults with BL.<\/p>\n<p><strong>Methods<\/strong><\/p>\n<p>A systematic review was conducted. Medline, EMBASE, and CENTRAL were searched from inception to February 22, 2022. Randomized or non-randomized clinical trials and longitudinal observational studies were eligible for inclusion. Reference screening, data extraction, and risk-of-bias assessment were conducted independently and in duplicate. Publication bias was examined by visual inspection of funnel plots. Meta-analyses were conducted when appropriate using Review Manager 5. The certainty of evidence was assessed using GRADE.<\/p>\n<p><strong>Results<\/strong><\/p>\n<p>The search identified 1119 references. Of these, 76 papers were selected for full-text assessment and 36 studies (N\u2009=\u200910,882) reported in 39 articles were eligible for inclusion. Older age, higher performance status, and central nervous system involvement were associated with poorer overall survival (OS) and progression-free survival (PFS). Black patients exhibited significantly lower OS and relative survival. Bone marrow involvement and higher albumin levels were associated with poorer OS. Treatment with rituximab, and with methotrexate were associated with better OS and PFS.<\/p>\n<p><strong>Conclusion<\/strong><\/p>\n<p>This study provides a comprehensive and methodologically rigorous evidence review on PFs in adults with BL. Several significant associations of PFs and survival estimates were observed, therefore, providing data to inform treatment decisions and to improve patient care.<\/p>\n<p>&nbsp;<\/p>\n<p>You can read the full article <a href=\"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/cam4.70513#\" target=\"_blank\" rel=\"noopener\">here<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Aythami de Armas-Castellano, Diego Infante Ventura, Tasmania del Pino-Sede\u00f1o, Yadira Gonz\u00e1lez Hern\u00e1ndez, Ra\u00fal Quir\u00f3s, Beatriz Le\u00f3n-Salas, Vicente Ribrag, Mar\u00eda M. &hellip; <\/p>\n","protected":false},"author":3,"featured_media":6868,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"ngg_post_thumbnail":0,"footnotes":""},"categories":[229,105],"tags":[],"class_list":["post-12218","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-featured","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>SESCS PUBLICATION: Prognostic Factors for Survival in Adults With Burkitt Lymphoma: A Systematic Review | SESCS<\/title>\n<meta name=\"description\" content=\"Mantente al d\u00eda de las novedades del Servicio de Evaluaci\u00f3n y Planificaci\u00f3n del Servicio Canario de la Salud (SESCS).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/sescs.es\/en\/prognostic-factors-survival-adult-burkitt-lymphoma\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SESCS PUBLICATION: Prognostic Factors for Survival in Adults With Burkitt Lymphoma: A Systematic Review | SESCS\" \/>\n<meta property=\"og:description\" content=\"Mantente al d\u00eda de las novedades del Servicio de Evaluaci\u00f3n y Planificaci\u00f3n del Servicio Canario de la Salud (SESCS).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/sescs.es\/en\/prognostic-factors-survival-adult-burkitt-lymphoma\/\" \/>\n<meta property=\"og:site_name\" content=\"SESCS\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SESCS2018\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-16T16:05:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/sescs.es\/wp-content\/uploads\/2025\/12\/Imagen-Articulo-Aythamy-Burkitt-Lymphoma.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"DifusionSESCS\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@_SESCS_\" \/>\n<meta name=\"twitter:site\" content=\"@_SESCS_\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"DifusionSESCS\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/sescs.es\/en\/prognostic-factors-survival-adult-burkitt-lymphoma\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/sescs.es\/en\/prognostic-factors-survival-adult-burkitt-lymphoma\/\"},\"author\":{\"name\":\"DifusionSESCS\",\"@id\":\"https:\/\/sescs.es\/#\/schema\/person\/0afad8715d2bf9946320c765357c64b4\"},\"headline\":\"SESCS PUBLICATION: Prognostic Factors for Survival in Adults With Burkitt Lymphoma: A Systematic Review\",\"datePublished\":\"2025-12-16T16:05:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/sescs.es\/en\/prognostic-factors-survival-adult-burkitt-lymphoma\/\"},\"wordCount\":306,\"publisher\":{\"@id\":\"https:\/\/sescs.es\/#organization\"},\"image\":{\"@id\":\"https:\/\/sescs.es\/en\/prognostic-factors-survival-adult-burkitt-lymphoma\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/sescs.es\/wp-content\/uploads\/2022\/11\/Imagen-noticia-Sescs-2.jpg\",\"articleSection\":[\"Featured\",\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/sescs.es\/en\/prognostic-factors-survival-adult-burkitt-lymphoma\/\",\"url\":\"https:\/\/sescs.es\/en\/prognostic-factors-survival-adult-burkitt-lymphoma\/\",\"name\":\"SESCS PUBLICATION: Prognostic Factors for Survival in Adults With Burkitt Lymphoma: A Systematic Review | SESCS\",\"isPartOf\":{\"@id\":\"https:\/\/sescs.es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/sescs.es\/en\/prognostic-factors-survival-adult-burkitt-lymphoma\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/sescs.es\/en\/prognostic-factors-survival-adult-burkitt-lymphoma\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/sescs.es\/wp-content\/uploads\/2022\/11\/Imagen-noticia-Sescs-2.jpg\",\"datePublished\":\"2025-12-16T16:05:49+00:00\",\"description\":\"Mantente al d\u00eda de las novedades del Servicio de Evaluaci\u00f3n y Planificaci\u00f3n del Servicio Canario de la Salud (SESCS).\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/sescs.es\/en\/prognostic-factors-survival-adult-burkitt-lymphoma\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/sescs.es\/en\/prognostic-factors-survival-adult-burkitt-lymphoma\/#primaryimage\",\"url\":\"https:\/\/sescs.es\/wp-content\/uploads\/2022\/11\/Imagen-noticia-Sescs-2.jpg\",\"contentUrl\":\"https:\/\/sescs.es\/wp-content\/uploads\/2022\/11\/Imagen-noticia-Sescs-2.jpg\",\"width\":956,\"height\":507,\"caption\":\"Predictores sociodemogr\u00e1ficos y cl\u00ednicos de la adherencia a los antidepresivos en los trastornos depresivos: una revisi\u00f3n sistem\u00e1tica con un metan\u00e1lisis\"},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/sescs.es\/#website\",\"url\":\"https:\/\/sescs.es\/\",\"name\":\"SESCS\",\"description\":\"Servicio de Evaluaci\u00f3n del Servicio Canario de Salud - Reduciendo la incertidumbre en las decisiones\",\"publisher\":{\"@id\":\"https:\/\/sescs.es\/#organization\"},\"alternateName\":\"Servicio de Evaluaci\u00f3n del Servicio Canario de Salud\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/sescs.es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/sescs.es\/#organization\",\"name\":\"SESCS\",\"alternateName\":\"Servicio de Evaluaci\u00f3n del Servicio Canario de Salud\",\"url\":\"https:\/\/sescs.es\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/sescs.es\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/sescs.es\/wp-content\/uploads\/2022\/04\/Imagen-noticia-Sescs-2.png\",\"contentUrl\":\"https:\/\/sescs.es\/wp-content\/uploads\/2022\/04\/Imagen-noticia-Sescs-2.png\",\"width\":956,\"height\":507,\"caption\":\"SESCS\"},\"image\":{\"@id\":\"https:\/\/sescs.es\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SESCS2018\",\"https:\/\/x.com\/_SESCS_\",\"https:\/\/www.linkedin.com\/company\/sescs-canarias\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/sescs.es\/#\/schema\/person\/0afad8715d2bf9946320c765357c64b4\",\"name\":\"DifusionSESCS\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/c24f11df1d2d674dcd9fa2615e7ce27c9c510cedb6048bb0e9f2e622d2334ddc?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/c24f11df1d2d674dcd9fa2615e7ce27c9c510cedb6048bb0e9f2e622d2334ddc?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/c24f11df1d2d674dcd9fa2615e7ce27c9c510cedb6048bb0e9f2e622d2334ddc?s=96&d=mm&r=g\",\"caption\":\"DifusionSESCS\"},\"url\":\"https:\/\/sescs.es\/en\/author\/difusionsescs\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SESCS PUBLICATION: Prognostic Factors for Survival in Adults With Burkitt Lymphoma: A Systematic Review | SESCS","description":"Mantente al d\u00eda de las novedades del Servicio de Evaluaci\u00f3n y Planificaci\u00f3n del Servicio Canario de la Salud (SESCS).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/sescs.es\/en\/prognostic-factors-survival-adult-burkitt-lymphoma\/","og_locale":"en_US","og_type":"article","og_title":"SESCS PUBLICATION: Prognostic Factors for Survival in Adults With Burkitt Lymphoma: A Systematic Review | SESCS","og_description":"Mantente al d\u00eda de las novedades del Servicio de Evaluaci\u00f3n y Planificaci\u00f3n del Servicio Canario de la Salud (SESCS).","og_url":"https:\/\/sescs.es\/en\/prognostic-factors-survival-adult-burkitt-lymphoma\/","og_site_name":"SESCS","article_publisher":"https:\/\/www.facebook.com\/SESCS2018","article_published_time":"2025-12-16T16:05:49+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/sescs.es\/wp-content\/uploads\/2025\/12\/Imagen-Articulo-Aythamy-Burkitt-Lymphoma.jpg","type":"image\/jpeg"}],"author":"DifusionSESCS","twitter_card":"summary_large_image","twitter_creator":"@_SESCS_","twitter_site":"@_SESCS_","twitter_misc":{"Written by":"DifusionSESCS","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/sescs.es\/en\/prognostic-factors-survival-adult-burkitt-lymphoma\/#article","isPartOf":{"@id":"https:\/\/sescs.es\/en\/prognostic-factors-survival-adult-burkitt-lymphoma\/"},"author":{"name":"DifusionSESCS","@id":"https:\/\/sescs.es\/#\/schema\/person\/0afad8715d2bf9946320c765357c64b4"},"headline":"SESCS PUBLICATION: Prognostic Factors for Survival in Adults With Burkitt Lymphoma: A Systematic Review","datePublished":"2025-12-16T16:05:49+00:00","mainEntityOfPage":{"@id":"https:\/\/sescs.es\/en\/prognostic-factors-survival-adult-burkitt-lymphoma\/"},"wordCount":306,"publisher":{"@id":"https:\/\/sescs.es\/#organization"},"image":{"@id":"https:\/\/sescs.es\/en\/prognostic-factors-survival-adult-burkitt-lymphoma\/#primaryimage"},"thumbnailUrl":"https:\/\/sescs.es\/wp-content\/uploads\/2022\/11\/Imagen-noticia-Sescs-2.jpg","articleSection":["Featured","News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/sescs.es\/en\/prognostic-factors-survival-adult-burkitt-lymphoma\/","url":"https:\/\/sescs.es\/en\/prognostic-factors-survival-adult-burkitt-lymphoma\/","name":"SESCS PUBLICATION: Prognostic Factors for Survival in Adults With Burkitt Lymphoma: A Systematic Review | SESCS","isPartOf":{"@id":"https:\/\/sescs.es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/sescs.es\/en\/prognostic-factors-survival-adult-burkitt-lymphoma\/#primaryimage"},"image":{"@id":"https:\/\/sescs.es\/en\/prognostic-factors-survival-adult-burkitt-lymphoma\/#primaryimage"},"thumbnailUrl":"https:\/\/sescs.es\/wp-content\/uploads\/2022\/11\/Imagen-noticia-Sescs-2.jpg","datePublished":"2025-12-16T16:05:49+00:00","description":"Mantente al d\u00eda de las novedades del Servicio de Evaluaci\u00f3n y Planificaci\u00f3n del Servicio Canario de la Salud (SESCS).","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/sescs.es\/en\/prognostic-factors-survival-adult-burkitt-lymphoma\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/sescs.es\/en\/prognostic-factors-survival-adult-burkitt-lymphoma\/#primaryimage","url":"https:\/\/sescs.es\/wp-content\/uploads\/2022\/11\/Imagen-noticia-Sescs-2.jpg","contentUrl":"https:\/\/sescs.es\/wp-content\/uploads\/2022\/11\/Imagen-noticia-Sescs-2.jpg","width":956,"height":507,"caption":"Predictores sociodemogr\u00e1ficos y cl\u00ednicos de la adherencia a los antidepresivos en los trastornos depresivos: una revisi\u00f3n sistem\u00e1tica con un metan\u00e1lisis"},{"@type":"WebSite","@id":"https:\/\/sescs.es\/#website","url":"https:\/\/sescs.es\/","name":"SESCS","description":"Servicio de Evaluaci\u00f3n del Servicio Canario de Salud - Reduciendo la incertidumbre en las decisiones","publisher":{"@id":"https:\/\/sescs.es\/#organization"},"alternateName":"Servicio de Evaluaci\u00f3n del Servicio Canario de Salud","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/sescs.es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/sescs.es\/#organization","name":"SESCS","alternateName":"Servicio de Evaluaci\u00f3n del Servicio Canario de Salud","url":"https:\/\/sescs.es\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/sescs.es\/#\/schema\/logo\/image\/","url":"https:\/\/sescs.es\/wp-content\/uploads\/2022\/04\/Imagen-noticia-Sescs-2.png","contentUrl":"https:\/\/sescs.es\/wp-content\/uploads\/2022\/04\/Imagen-noticia-Sescs-2.png","width":956,"height":507,"caption":"SESCS"},"image":{"@id":"https:\/\/sescs.es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SESCS2018","https:\/\/x.com\/_SESCS_","https:\/\/www.linkedin.com\/company\/sescs-canarias\/"]},{"@type":"Person","@id":"https:\/\/sescs.es\/#\/schema\/person\/0afad8715d2bf9946320c765357c64b4","name":"DifusionSESCS","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/c24f11df1d2d674dcd9fa2615e7ce27c9c510cedb6048bb0e9f2e622d2334ddc?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/c24f11df1d2d674dcd9fa2615e7ce27c9c510cedb6048bb0e9f2e622d2334ddc?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c24f11df1d2d674dcd9fa2615e7ce27c9c510cedb6048bb0e9f2e622d2334ddc?s=96&d=mm&r=g","caption":"DifusionSESCS"},"url":"https:\/\/sescs.es\/en\/author\/difusionsescs\/"}]}},"_links":{"self":[{"href":"https:\/\/sescs.es\/en\/wp-json\/wp\/v2\/posts\/12218","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/sescs.es\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/sescs.es\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/sescs.es\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/sescs.es\/en\/wp-json\/wp\/v2\/comments?post=12218"}],"version-history":[{"count":1,"href":"https:\/\/sescs.es\/en\/wp-json\/wp\/v2\/posts\/12218\/revisions"}],"predecessor-version":[{"id":12219,"href":"https:\/\/sescs.es\/en\/wp-json\/wp\/v2\/posts\/12218\/revisions\/12219"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/sescs.es\/en\/wp-json\/wp\/v2\/media\/6868"}],"wp:attachment":[{"href":"https:\/\/sescs.es\/en\/wp-json\/wp\/v2\/media?parent=12218"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/sescs.es\/en\/wp-json\/wp\/v2\/categories?post=12218"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/sescs.es\/en\/wp-json\/wp\/v2\/tags?post=12218"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}